Riskpilot← Back to searchSign inGet full accessSCAN-MED. A/S. DENMARK
A/SActiveCVR 14472800Dalgårdsvej 17Wholesale of pharmaceutical and medical goods · NACE 4646Est. 199011 employees
Revenue 2025
DKK 12,8M
+24% vs 2024
EBITDA margin
34.5%
+66% vs 2024
Equity ratio
65.0%
Financial strength
Net profit 2025
DKK 3,4M
+77% vs 2024
| Revenue | DKK 12,8M | +24% |
| EBITDA | DKK 4,4M | +66% |
| Net profit | DKK 3,4M | +77% |
| Total assets | DKK 24,4M | +27% |
| Equity | DKK 15,8M | +18% |
| Employees | 11 | — |
Legal name
SCAN-MED. A/S. DENMARK
CVR number
14472800
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. september 1990
Share capital
DKK 1.606.269
Employees
11 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand og ét bestyrelsesmedlem eller af selskabets direktør og ét bestyrelsesmedlem.
Company purpose
Selskabets formål er at drive handel og service i ind- og udland inden for det medicinske område.
Address
Dalgårdsvej 17
Email
scan-med@scan-med.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.280 | 5.304 | 4.742 | 5.192 | 6.484 | 7.727 | 7.726 | 6.082 | 6.303 | 7.527 | 14.713 | 10.762 | 10.313 | 12.764 |
| Staff expenses | -4.262 | -4.245 | -4.470 | -4.343 | -4.690 | -5.992 | -6.197 | -5.902 | -6.088 | -6.376 | -8.685 | -7.465 | -7.660 | -8.355 |
| EBITDA | 1.018 | 1.059 | 272 | 849 | 1.795 | 1.736 | 1.529 | 180 | 215 | 1.150 | 6.028 | 3.297 | 2.653 | 4.409 |
| Depreciation & amort. | -249 | -208 | -176 | -168 | -39 | -47 | -54 | -16 | -18 | -17 | -15 | -76 | -76 | -76 |
| EBIT | 769 | 851 | 96 | 681 | 1.756 | 1.688 | 1.475 | 164 | 197 | 1.133 | 6.013 | 3.221 | 2.577 | 4.333 |
| Net financials | 19 | -2 | -93 | -13 | -10 | -16 | -104 | 7 | -4 | -31 | -308 | -167 | -85 | 81 |
| Profit before tax | 787 | 849 | 3 | 668 | 1.746 | 1.673 | 1.370 | 171 | 193 | 1.102 | 5.704 | 3.054 | 2.492 | 4.414 |
| Tax | 197 | 212 | 3 | 160 | 386 | 368 | 302 | 38 | 43 | 243 | 1.259 | 673 | 551 | 975 |
| Net profit | 590 | 637 | 0 | 508 | 1.360 | 1.305 | 1.069 | 133 | 149 | 860 | 4.445 | 2.380 | 1.941 | 3.439 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8.818 | 8.450 | 9.037 | 8.698 | 11.648 | 12.304 | 12.232 | 9.942 | 12.409 | 13.473 | 26.426 | 21.374 | 19.277 | 24.394 |
| Equity | 6.122 | 5.759 | 5.159 | 5.668 | 7.027 | 7.332 | 7.201 | 6.334 | 6.483 | 7.194 | 15.089 | 13.469 | 13.410 | 15.849 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 173 | 373 | 380 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.602 | 2.642 | 3.864 | 3.030 | 4.621 | 4.972 | 5.031 | 3.435 | 5.553 | 5.900 | 11.337 | 7.905 | 5.844 | 8.532 |
| Total debt | 2.602 | 2.642 | 3.864 | 3.030 | 4.621 | 4.972 | 5.031 | 3.608 | 5.926 | 6.280 | 11.337 | 7.905 | 5.844 | 8.532 |
EBITDA margin
34.5%
This company
15.8%
Market median
+118% vs market
20122025
Equity ratio
65.0%
This company
38.2%
Market median
+70% vs market
20122025
Return on equity
21.7%
This company
18.4%
Market median
+18% vs market
20122025
Net profit margin
26.9%
This company
8.1%
Market median
+232% vs market
20122025
Asset turnover
0.52×
This company
1.12×
Market median
-54% vs market
20122025
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BL Management | Management | 1990 | — | — |
KW Management | Management | 2017 | — | — |
KE Management | Management | 1990 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2012 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 1998 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2017 | |
ASKI HOLDING ApS | Company | 25.0% | 25.0% | 2009 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SCAN-MED. A/S. DENMARK also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Børge Lykke Nielsen | Management | 0 companies |
| Kirsten Willis | Management | 0 companies |
| Knud Erik Kaadner | Management | 0 companies |
| Klaus Erik Johansen | Board of Directors | 0 companies |
| Bjørn Helmer Johnsen | Chairman | 0 companies |
| Lars Sigurd Brock | Board of Directors | 0 companies |